Literature DB >> 31426017

The Cost-Effectiveness of Continuous Versus Intermittent Renal Replacement Therapies in Acute Kidney Injury: Perspective of the Social Services for the Elderly in Argentina.

Osvaldo Ulises Garay1, Alfredo Palacios2, Andrés Pichon-Riviere2, Federico Augustovski2, Sebastián García Martí2, Akram Hernández-Vásquez2, Elena Tapia López2, Guillermo Rosa-Díez3, Ariel Bardach2.   

Abstract

BACKGROUND: Acute kidney injury (AKI) is a public health problem that affects millions of hospitalized patients worldwide. In Argentina, evidence suggests that its incidence has risen in recent years. When severe, AKI may require a renal replacement therapy (RRT) where continuous RRT (CRRT) and intermittent RRT (IRRT) are plausible options for patients in the intensive care unit.
OBJECTIVE: To evaluate the cost utility of CRRT versus IRRT for the National Institute of Social Services for Retirees and Pensioners, the largest social security health insurance for elders in Argentina.
METHODS: This was a model-based cost-utility analysis. Long-term costs and health outcomes were estimated for a hypothetical cohort with a Markov model. Parameters used were obtained from published literature and validated with local experts. Local costs were estimated and expressed in $AR of 2016. Several sensitivity analyses were run to analyze the impact of uncertainty on results.
RESULTS: Continuous RRT dominated IRRT by cumulating over the model more quality-adjusted life years and less costs. Total discounted quality-adjusted life years for both cohorts were 1049 and 1034, respectively, and total costs were $95 362 and $103 871. Cost-effectiveness (CE) results reflect these differences in favor of CRRT with a deterministic cost-saving incremental CE ratio and a probability of CRRT being CE of 65.4%, considering a CE threshold of 1 gross domestic product per capita.
CONCLUSIONS: Continuous RRT for patients with AKI eligible for CRRT or IRRT would probably be a cost-effective intervention for the National Institute of Social Services for Retirees and Pensioners' view. Nevertheless, there is considerable uncertainty around results, mainly due to the lack of adequate controlled studies and local data on the prognosis of these patients in Argentina.
Copyright © 2019 ISPOR--The professional society for health economics and outcomes research. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute kidney injury; health economic evaluation; renal replacement therapy

Mesh:

Year:  2019        PMID: 31426017     DOI: 10.1016/j.vhri.2019.03.008

Source DB:  PubMed          Journal:  Value Health Reg Issues        ISSN: 2212-1099


  4 in total

1.  The Use of Expert Elicitation among Computational Modeling Studies in Health Research: A Systematic Review.

Authors:  Christopher J Cadham; Marie Knoll; Luz María Sánchez-Romero; K Michael Cummings; Clifford E Douglas; Alex Liber; David Mendez; Rafael Meza; Ritesh Mistry; Aylin Sertkaya; Nargiz Travis; David T Levy
Journal:  Med Decis Making       Date:  2021-10-25       Impact factor: 2.749

2.  Cost-effectiveness of a centrifugal-flow pump for patients with advanced heart failure in Argentina.

Authors:  Andrea Alcaraz; Andres Pichon-Riviere; Carlos Rojas-Roque; Juan Martín González; Daniela Prina; Germán Solioz; Federico Augustovski; Alfredo Palacios
Journal:  PLoS One       Date:  2022-08-01       Impact factor: 3.752

3.  Improving the monitoring of chronic heart failure in Argentina: is the implantable pulmonary artery pressure with CardioMEMS Heart Failure System cost-effective?

Authors:  Andrea Alcaraz; Carlos Rojas-Roque; Daniela Prina; Juan Martín González; Andrés Pichon-Riviere; Federico Augustovski; Alfredo Palacios
Journal:  Cost Eff Resour Alloc       Date:  2021-07-09

4.  Cost-effectiveness of the TherMax blood warmer during continuous renal replacement therapy.

Authors:  Michael J Blackowicz; Max Bell; Jorge Echeverri; Kai Harenski; Marcus E Broman
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.